An Australian biotech company is already turning heads so far on Wednesday after it was announced results from its GBM-AGILE, which is a phase II/III study that included an...

To read the full story on AllPennyStocks.com, click here.

Kazia Therapeutics (NASDAQ:KZIA)
過去 株価チャート
から 6 2024 まで 7 2024 Kazia Therapeuticsのチャートをもっと見るにはこちらをクリック
Kazia Therapeutics (NASDAQ:KZIA)
過去 株価チャート
から 7 2023 まで 7 2024 Kazia Therapeuticsのチャートをもっと見るにはこちらをクリック